1. Differential modulation by interferon γ of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens

   • Alexei F. Kirkin
   • P. thor Straten
   • J. Zeuthen

   ORIGINAL ARTICLE Pages: 203 - 212

2. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D₃ treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells

   • M. Margaret Prechel
   • Yvonne Lozano
   • M. R. I. Young

   ORIGINAL ARTICLE Pages: 213 - 220

3. Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2

   • M. J. Ehrke
   • Srdan Verstovšek
   • Enrico Mihich

   ORIGINAL ARTICLE Pages: 221 - 230

4. Involvement of tumor necrosis factor α and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis

   • A. Higashiyama
   • Hideaki Watanabe
   • Hideo Yagita

   ORIGINAL ARTICLE Pages: 231 - 236

5. Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes

   • Marjorie J. Arca
   • John C. Krauss
   • A. E. Chang

   ORIGINAL ARTICLE Pages: 237 - 245

6. Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding

   • C. A. McIntyre
   • Robert C. Rees
   • Anna K. Murray

   ORIGINAL ARTICLE Pages: 246 - 250

7. An indicator quantitatively comparing two treatment effect sizes on responder and non-responder groups  –  exponential of estimated interaction parameter

   • M. Sugita
   • Takashi Izuno
   • Toshio Mitomi

   ORIGINAL ARTICLE Pages: 251 - 254

8. Intradermal administration of lipopolysaccharide in treatment of human cancer

   • Shigenori Goto
   • Sumitaka Sakai
   • Shoshichi Takeuchi

   ORIGINAL ARTICLE Pages: 255 - 261